Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 - DRAGON PHARMACEUTICAL INC | dragon10k091231.htm |
| EX-23.2 - CONSENT OF ERNST & YOUNG LLP - DRAGON PHARMACEUTICAL INC | exhibit23-2.htm |
| EX-31.2 - SOX SECTION 302 CFO CERTIFICATION - DRAGON PHARMACEUTICAL INC | exhibit31-2.htm |
| EX-31.1 - SOX SECTION 302 CEO CERTIFICATION - DRAGON PHARMACEUTICAL INC | exhibit31-1.htm |
| EX-23.1 - CONSENT OF CHANG LEE LLP - DRAGON PHARMACEUTICAL INC | exhibit23-1.htm |
Exhibit 32
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of Dragon Pharmaceutical Inc., a Florida corporation (the “Company”), does hereby certify with respect to the Annual Report of the Company on Form 10-K for the year ended December 31, 2009 as filed with the Securities and Exchange Commission (the “Form 10-K”) that, to the best of their knowledge:
(1) the Form 10-K fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: March 31, 2010 |
/s/ Yanlin Han |
|
|
Yanlin Han Chairman and Chief Executive Officer (Principal Executive Officer) |
|
Dated: March 31, 2010 |
/s/ Garry Wong |
|
|
Garry Wong (Principal Financial Officer) |